- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
AMGN
Amgen to Buy Celgene’s Otezla for $13.4B: Is the Deal Good for Amgen Stock?
Amgen's purchase of Celgenes blockbuster psoriasis drug, Otezla is likely to strengthen its position in the immunology space and boost Amgen stock.
Stock Market Today: Biotech in Focus, Trade Talks Steady Stocks
Trade talks gave a lift to stocks, while Johnson & Johnson will be in focus after the close. Here's what happened in the stock market today.
5 Top Stock Trades for Tuesday: NFLX, AMGN, ACB, BMY
Netflix, Amgen, Bristol-Myers Squibb, Aurora Cannabis and Foot Locker are our top stock trades for Tuesday. Here's how to trade them.
Celgene News: CELG Stock Jumps on Sale of Otezla to Amgen
Celgene news for Thursday about it selling Otezla has CELG stock on the rise as it moves forward with the Bristol-Myers Squibb merger.
Wednesday’s Vital Data: Amgen, American Airlines and Apple
Options trading was buzzing on Tuesday, with Amgen, American Airlines and Apple all making notable moves. Here are the metrics that matter moving forward.
9 Catalysts That Will Drive Chinese Biotech Stocks Much Higher
Matt McCall is extremely bullish on China and the big opportunities in several sectors, but Chinese biotech stocks top his list.
5 Top Stock Trades for Thursday: CVS, TWLO, EL, AMGN
CVS, Twilio, Amgen and Estee Lauder all reported earnings. Alibaba stock is breaking out. Here are our top stock trades to watch now.
Amgen Earnings: AMGN Stock Dips Slightly Despite Q1 EPS, Sales Beat
Amgen reported its latest quarterly earnings results after hours today, bringing in a profit that topped expectations, yet AMGN stock fell.
3 Big Stock Charts for Thursday: Citrix Systems, Goldman Sachs Group and Amgen
The stock charts of AMGN, CTXS and GS stock are ready to start the last trading day of the week on a trade-worthy foot.
Why Amgen Stock Could Break Out to New Highs
Amgen shares have a reasonable valuation, 3% dividend yield and a strong-looking chart. Is it time to buy AMGN stock now?